The researchers examined the impact of the 13-valent pneumococcal conjugate vaccine (13vPCV) on childhoodpneumoniaand empyema—complicated pneumonia—after its introduction to the Australian National Immunisation Program about a decade ago. The new study, published inThoraxrecently, found that while 13vP...
Routine infant immunisation with seven-valent pneumococcal conjugate vaccine (PCV7) began in the USA in 2000. Although invasive pneumococcal disease has declined substantially, the programme's effect on hospital admissions for pneumonia is unknown. We therefore assessed the effect of the programme ...
Most studies of Haemophilus influenzae type b (Hib) disease in Asia have found low rates, and few Asian countries use Hib vaccine in routine immunisation p... BD Gessner,A Sutanto,M Linehan,... - 《Lancet》 被引量: 376发表: 2005年 Incidences of vaccine-preventable Haemophilus influenzae ...
The impact of childhood pneumococcal conjugate vaccine immunisation on all-cause pneumonia admissions in Hong Kong: A 14-year population-based interrupted ... The impact of childhood pneumococcal conjugate vaccine immunisation on all-cause pneumonia admissions in Hong Kong: A 14-year population-based ...
to achieve even a 50 per cent pneumococcal vaccination rate among equally vulnerable seniors, despite the publicly-funded immunisation program – a simple preventative health measure that could prevent serious disease or premature death," says Dr Menzies, of the UNSW Vaccine and Infection Research Lab...
CONCLUSIONS: Available data suggest that the proportion of CAP attributable to pneumococcus (both bacteraemic and non-bacteraemic) has been declining in Australian adults. Should 13vPCV replace the 23vPPV currently funded by the National Immunisation Program for persons aged 65 years, surveillance ...
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysisCarlos G Grijalva MD aJ Pekka Nuorti MD gPatrick G Arbogast PhD a bStacey W Martin MSc gProf Kathryn M Edwards MD d...
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.The article discusses research regarding the effectiveness of the pneumococcal vaccine in the U.S. Researchers studied data from the Nationwide Inpatient Sample, the ...
Vaccine
Background In October, 2012, Fiji introduced routine infant immunisation with a ten-valent pneumococcal conjugate vaccine (PCV10) using three primary doses and no booster dose (3 + 0 schedule). Data are scarce for the effect of PCV in the Asia and Pacific region. We aimed to evaluate the...